Mostaza 2020
Clinical course and prognostic factors of COVID-19 infection in an elderly hospitalized population
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (2)
Sharifi 2020
Estimating COVID-19-Related Infections, Deaths, and Hospitalizations in Iran Under Different Physical Distancing and Isolation Scenarios
  1. Study Type
  2. Modelling
  1. Study Aim
  2. Transmission
  3. Epidemiology
  4. Prevention
  1. Study Design
  2. Other
  1. Intervention Assignment
  2. Not Applicable
References (2)
Zheng 2020ah
Impact of sex and age on respiratory support and length of hospital stay among 1792 patients with COVID-19 in Wuhan, China
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  3. Epidemiology
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (2)
Chang 2020r
Factors related to preventive COVID-19 infection behaviors among people with mental illness
  1. Study Type
  2. Qualitative
  1. Study Aim
  2. Transmission
  3. Epidemiology
  4. Prevention
  1. Study Design
  2. Cross-sectional
  1. Intervention Assignment
  2. Not Applicable
References (2)
Lyons 2020a
COVID-19 and the mental well-being of Australian medical students: impact, concerns and coping strategies used
  1. Study Type
  2. Qualitative
  1. Study Aim
  2. Other
  3. Health Services Research
  1. Study Design
  2. Cross-sectional
  1. Intervention Assignment
  2. Not Applicable
References (1)
Inciarte 2020
Clinical characteristics, risk factors, and incidence of symptomatic COVID-19 in adults living with HIV: a single-center, prospective observational study
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  3. Epidemiology
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (2)
NCT04510207
Multicenter, Randomized, Double Blind, Parallel Placebo Controlled, Phase III Clinical Trial to Evaluate the Protective Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above
  1. Study Type
  2. Interventional
  1. Study Aim
  2. Prevention
  1. Study Design
  2. Parallel/Crossover
  1. Intervention Assignment
  2. Randomised
References (1)
NCT04510623
Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Angiotensin II Type 1 Receptor Blockers (ARBs) on Outcomes of Coronavirus Infection?
  1. Study Type
  2. Observational
  1. Study Aim
  2. Treatment and Management
  3. Mechanism
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (3)
NCT04510038
Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19)
  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Parallel/Crossover
  1. Intervention Assignment
  2. Randomised
  1. Population (7)
  2. Male and Female
  3. Cardiac injury associated with COVID-19
  4. Adult
  5. Aged (65+)
  1. Intervention (2)
  2. Colchicine
  3. Usual Care
  1. Comparison (1)
  2. Usual Care
  1. Outcome (11)
  2. All Cause Mortality
  3. C-reactive Protein
  4. Troponin
  5. Clinical deterioration
  6. Adverse Event
  7. Hospitalization
  8. Circulatory Care
  9. Mechanical ventilation
  10. D-dimer Assay
  11. Brain Natriuretic Peptide Measurement
  12. Duration Of Hospital Stay
References (2)
NCT04511650
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Dose Escalation and Proof-of-Concept Study to Evaluate the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19) (RESCUE Study)
  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Parallel/Crossover
  1. Intervention Assignment
  2. Randomised
References (1)
Chiarello 2020
Assessment of severity of acute pancreatitis in a Sars-CoV-2 pandemia
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (1)
Giannattasio 2020
A child with a severe multisystem inflammatory syndrome following an asymptomatic COVID-19 infection: a novel management for a new disease?
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  3. Treatment and Management
  1. Study Design
  2. Case Report
  1. Intervention Assignment
  2. Not Applicable
References (1)
Teherani 2020
Burden of illness in households with SARS-CoV-2 infected children
  1. Study Type
  2. Observational
  1. Study Aim
  2. Transmission
  3. Diagnostic/Prognostic
  4. Epidemiology
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (1)
Ogawa 2020a
Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  3. Treatment and Management
  1. Study Design
  2. Case Report
  1. Intervention Assignment
  2. Not Applicable
References (1)
Fengmin 2020
The absorbing filter Oxiris in severe COVID-19 patients: a case series
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  3. Treatment and Management
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (1)
0 Selected
ExportClear